Literature DB >> 4117662

Ultrastructural cytochemical demonstration of tartrate-resistant acid phosphatase isoenzyme activity in "hairy cells" of leukemic reticuloendotheliosis.

I Katayama, C Y Li, L T Yam.   

Abstract

The pathognomonic "hairy cell" of leukemic reticuloendotheliosis was studied for ultrastructural localization of tartrate-resistant acid phosphatase activity. The enzyme activity could not be demonstrated by Gomori's method, but it was readily demonstrated in the cytoplasmic vesicles and Golgi saccules of the hairy cell by substitution of naphthol AS-BI phosphoric acid for Na-beta-glycerophosphate of Gomori's medium. This apparent substrate specificity may be used as a marker for electron microscopic identification of the hairy cell, and may facilitate the study of histogenesis of leukemic reticuloendotheliosis.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4117662      PMCID: PMC2032805     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Species variability and the substrate specificity of intracellular acid phosphatases: a comparison of the lead-salt and azo-dye methods.

Authors:  R M ROSENBAUM; C I ROLON
Journal:  Z Zellforch Microsk Anat Histochem       Date:  1962

2.  Histochemical study of acid phosphatase isoenzyme in leukemic reticuloendotheliosis.

Authors:  I Katayama; C Y Li; L T Yam
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

3.  Leukemic reticuloendotheliosis. Electron microscopy of circulating lymphoid cells.

Authors:  F Padilla; B L Soloff
Journal:  Nouv Rev Fr Hematol       Date:  1971 Jul-Aug

4.  Ultrastructure of hairy cell leukemia.

Authors:  F N Ghadially; L F Skinnider
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

5.  The ultrastructure of lymphocytes.

Authors:  D Zucker-Franklin
Journal:  Semin Hematol       Date:  1969-01       Impact factor: 3.851

6.  p-(acetoxymercuric) aniline diazotate, a reagent for visualizing the naphthol AS-BI product of acid hydrolase action at the level of the light and electron microscope.

Authors:  R E Smith; W H Fishman
Journal:  J Histochem Cytochem       Date:  1969-01       Impact factor: 2.479

7.  Chronic reticulolymphocytic leukemia. Reclassification of "leukemic reticuloendotheliosis" through functional characterization of the circulating mononuclear cells.

Authors:  A D Rubin; S D Douglas; L N Chessin; P R Glade; W Dameshek
Journal:  Am J Med       Date:  1969-07       Impact factor: 4.965

8.  Ultrastructure of normal and leukemic leukocytes in human peripheral blood.

Authors:  D R Anderson
Journal:  J Ultrastruct Res       Date:  1966-09

9.  The development of neutrophilic polymorphonuclear leukocytes in human bone marrow.

Authors:  D F Bainton; J L Ullyot; M G Farquhar
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

10.  LYTIC ACTIVITIES IN RENAL PROTEIN ABSORPTION DROPLETS. AN ELECTRON MICROSCOPICAL CYTOCHEMICAL STUDY.

Authors:  F MILLER; G E PALADE
Journal:  J Cell Biol       Date:  1964-12       Impact factor: 10.539

View more
  4 in total

1.  Malignant histiocytosis with chronic course. Ultrastructural and ultrastructural cytochemical studies.

Authors:  M Shamoto; T Suchi
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-11-17

2.  Localisation of high acid phosphotyrosine phosphatase activity in afferent arterioles and glomeruli of human kidney.

Authors:  Seppo Partanen
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

3.  A histochemical study of the enzyme profile of Krabbe's cells.

Authors:  M Elleder
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

4.  Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders.

Authors:  Piers A Blombery; Stephen Q Wong; Chelsee A Hewitt; Alexander Dobrovic; Ellen L Maxwell; Surender Juneja; George Grigoriadis; David A Westerman
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.